DK0720598T3 - Phenoxyphenylcyclopentenyl-hydroxyurinstoffer - Google Patents

Phenoxyphenylcyclopentenyl-hydroxyurinstoffer

Info

Publication number
DK0720598T3
DK0720598T3 DK94922374T DK94922374T DK0720598T3 DK 0720598 T3 DK0720598 T3 DK 0720598T3 DK 94922374 T DK94922374 T DK 94922374T DK 94922374 T DK94922374 T DK 94922374T DK 0720598 T3 DK0720598 T3 DK 0720598T3
Authority
DK
Denmark
Prior art keywords
pct
date
above compounds
sec
hydrogen
Prior art date
Application number
DK94922374T
Other languages
English (en)
Inventor
Akiyoshi Kawai
Rodney W Stevens
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of DK0720598T3 publication Critical patent/DK0720598T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/64Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups singly-bound to oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/17Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/06Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/10Systems containing only non-condensed rings with a five-membered ring the ring being unsaturated

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polyurethanes Or Polyureas (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DK94922374T 1993-08-19 1994-08-15 Phenoxyphenylcyclopentenyl-hydroxyurinstoffer DK0720598T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP20545393 1993-08-19
PCT/JP1994/001349 WO1995005360A1 (en) 1993-08-19 1994-08-15 Phenoxyphenyl cyclopentenyl hydroxyureas

Publications (1)

Publication Number Publication Date
DK0720598T3 true DK0720598T3 (da) 1999-06-21

Family

ID=16507136

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94922374T DK0720598T3 (da) 1993-08-19 1994-08-15 Phenoxyphenylcyclopentenyl-hydroxyurinstoffer

Country Status (27)

Country Link
US (1) US5792882A (da)
EP (1) EP0720598B1 (da)
JP (1) JP2794343B2 (da)
KR (1) KR0170623B1 (da)
CN (1) CN1077568C (da)
AT (1) ATE171939T1 (da)
AU (1) AU674776B2 (da)
BR (1) BR9407314A (da)
CA (1) CA2169066C (da)
CO (1) CO4230229A1 (da)
CZ (1) CZ288358B6 (da)
DE (1) DE69413831T2 (da)
DK (1) DK0720598T3 (da)
EC (1) ECSP941144A (da)
EG (1) EG20530A (da)
ES (1) ES2121218T3 (da)
FI (1) FI114466B (da)
IL (1) IL110628A (da)
MY (1) MY111140A (da)
NO (1) NO305595B1 (da)
NZ (1) NZ269849A (da)
PE (1) PE57194A1 (da)
PL (1) PL176223B1 (da)
RU (1) RU2125987C1 (da)
TW (2) TW448144B (da)
WO (1) WO1995005360A1 (da)
ZA (1) ZA946253B (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EE9600184A (et) * 1994-06-27 1997-06-16 Cytomed, Inc. Kardiovaskulaar-, inflammatoor- ja immuunhaiguste raviühendid ja -meetodid
EP0790981B1 (en) * 1994-11-10 1999-09-08 Pfizer Inc. Aryloxycycloalkenyl and aryloxyiminocycloalkenylhydroxyureas as 5-lipoxygenase inhibitors
WO1996016054A1 (en) * 1994-11-18 1996-05-30 Pfizer Pharmaceuticals Inc. Cycloalkenyl-n-hydroxyureas
EP1741424B1 (en) 1997-08-11 2018-10-03 Pfizer Products Inc. Solid pharmaceutical dispersions with enhanced bioavailabilty
US6121323A (en) * 1997-12-03 2000-09-19 3M Innovative Properties Company Bishydroxyureas
DE602005025934D1 (de) * 2004-12-02 2011-02-24 Amorepacific Corp Die produktion von tnf-alpha inhibierenden 2-cyclopenten-1-onoximderivate
KR101494488B1 (ko) * 2007-12-03 2015-02-24 (주)아모레퍼시픽 2-사이클로펜텐-1-온 옥심 유도체를 유효성분으로 포함하는 지방대사질환 예방 및 치료용 약학 조성물
KR101739994B1 (ko) 2009-04-03 2017-05-25 에프. 호프만-라 로슈 아게 프로판-1-술폰산 {3-[5-(4-클로로-페닐)-1H-피롤로[2,3-b]피리딘-3-카르보닐]-2,4-디플루오로-페닐}-아미드 조성물 및 그의 용도
US8512464B2 (en) * 2009-12-02 2013-08-20 3M Innovative Properties Company Functionalized zirconia nanoparticles and high index films made therefrom

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ222168A (en) * 1986-10-20 1991-05-28 Oncogene Science Inc Tumour growth inhibiting protein related to tgf-#b#1 and tgf-#b#2, preparation by genetic engineering methods, antibodies and pharmaceutical compositions
US5026729A (en) * 1987-02-10 1991-06-25 Abbott Laboratories Lipoxygenase inhibiting compounds
CA2009201A1 (en) * 1989-02-03 1990-08-03 William Paul Jackson Anti-inflammatory aryl derivatives
US5037853A (en) * 1989-12-28 1991-08-06 Abbott Laboratories Cyclopropyl derivative lipoxygenase inhibitors
US5120752A (en) * 1989-12-28 1992-06-09 Abbott Laboratories Cyclopropyl derivative lipoxygenase inhibitors
GB9025514D0 (en) * 1990-11-23 1991-01-09 Wellcome Found Anti-inflammatory compounds
JP3007138B2 (ja) * 1990-11-27 2000-02-07 ファイザー製薬株式会社 新規なヒドロキサム酸とn―ヒドロキシ尿素誘導体およびそれらの組成物
JPH06256285A (ja) * 1990-12-11 1994-09-13 Pfizer Pharmaceut Co Ltd ヒドロキサム酸誘導体およびその用途
US5130485A (en) * 1991-04-23 1992-07-14 Eli Lilly And Company N-hydroxy-N-(3-(2-substituted phenyl)prop-2-enyl)ureas and thioureas useful as 5-lipoxygenase inhibiting agents
US5149097A (en) * 1991-05-01 1992-09-22 Tonello John H Crossword puzzle aid
JPH05163229A (ja) * 1991-12-13 1993-06-29 Pfizer Pharmaceut Co Ltd 新規なシクロプロピル誘導体
JPH05294921A (ja) * 1992-04-17 1993-11-09 Pfizer Pharmaceut Co Ltd 新規なフェニル置換シクロアルキル尿素誘導体および組成物

Also Published As

Publication number Publication date
WO1995005360A1 (en) 1995-02-23
CO4230229A1 (es) 1995-10-19
CZ288358B6 (en) 2001-05-16
FI943799A0 (fi) 1994-08-18
KR0170623B1 (ko) 1999-03-30
US5792882A (en) 1998-08-11
ZA946253B (en) 1996-02-19
RU2125987C1 (ru) 1999-02-10
AU674776B2 (en) 1997-01-09
EP0720598A1 (en) 1996-07-10
ATE171939T1 (de) 1998-10-15
FI943799L (fi) 1995-02-20
DE69413831T2 (de) 1999-02-25
ES2121218T3 (es) 1998-11-16
JPH08511031A (ja) 1996-11-19
NO960631D0 (no) 1996-02-16
NZ269849A (en) 1997-10-24
MY111140A (en) 1999-08-30
EP0720598B1 (en) 1998-10-07
CA2169066C (en) 1999-06-22
JP2794343B2 (ja) 1998-09-03
CZ48396A3 (en) 1996-07-17
CN1129440A (zh) 1996-08-21
IL110628A (en) 1998-12-27
TW448144B (en) 2001-08-01
DE69413831D1 (de) 1998-11-12
FI114466B (fi) 2004-10-29
ECSP941144A (es) 1995-02-27
NO305595B1 (no) 1999-06-28
CN1077568C (zh) 2002-01-09
AU7350994A (en) 1995-03-14
PL313037A1 (en) 1996-05-27
PE57194A1 (es) 1995-02-07
NO960631L (no) 1996-02-16
CA2169066A1 (en) 1995-02-23
EG20530A (en) 1999-07-31
TW418089B (en) 2001-01-11
KR960703845A (ko) 1996-08-31
BR9407314A (pt) 1996-04-16
IL110628A0 (en) 1994-11-11
PL176223B1 (pl) 1999-05-31

Similar Documents

Publication Publication Date Title
FI943948A0 (fi) Heterosykliset hiilihappojohdannaiset
ATE206123T1 (de) Phenylxanthin-derivate
FI932229A0 (fi) Azabicykliska bryggderivat
PT100606A (pt) Derivados fluoroalcoxibenzilamino de heterociclos contendo azoto
DE69505542D1 (de) 3-benzoylbenzofuran-derivate als thyroidhormonantagonisten
NO306345B1 (no) Piperidin-derivater med PAF antagonist-aktivitet, anvendelse derav og farmasöytisk blanding
ATE196293T1 (de) Triazole enthaltende antifungizide mittel
NO308654B1 (no) Amid-derivater, fremgangsmÕter og mellomprodukter for fremstilling derav, deres anvendelse og farmasøytiske blandinger som inneholdende dem
DK0720598T3 (da) Phenoxyphenylcyclopentenyl-hydroxyurinstoffer
ATE184593T1 (de) Aminosäurederivate und ihre verwendung als phospholipase-a2-inhibitoren
ATE144497T1 (de) N-substituierte 3-azabicyclo(3.2.0&gt;heptan- derivate als neuroleptika
IL113706A (en) N-hydroxyurea alkyl phenyl oxazoles and thiazoles uses thereof as anti-inflammatory agents and pharmaceutical compositions containing them
FI935867A0 (fi) Tetrahydrobensazepinderivat som inhibiterar lipoxigenas